Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Tomaderm AB
AB
Active
Org 5593481061
Erstagatan 23, 116 36
Stockholm
Restaurant activities
·
NACE 5611
Est. 2021 · 4 years old
1-4 employees
Monitor
Share
Sweden
/
Companies
/
Restaurant activities
/
Tomaderm AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2023: not reported
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
2026: 2M
2M
2026
EBITDA
SEK millions
1M
1M
1M
0M
0M
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
2026: 1M
1M
2026
Income statement
SEK thousands
Item
2026
2025
2024
2023
Revenue
1 773
461
50
—
Staff expenses
—
−87
−2
—
EBITDA
502
142
36
−7
Depreciation & amort.
−27
—
—
—
EBIT
475
142
36
−7
Net financials
—
0
0
−0
Profit before tax
474
142
36
−7
Tax
−111
−29
−6
—
Net profit
363
113
30
−7
Balance sheet
SEK thousands
Item
2026
2025
2024
2023
Total assets
1 011
320
68
23
Equity
524
161
48
18
Long-term debt
0
—
—
—
Short-term debt
486
159
21
5
Total debt
486
159
21
5
Financial ratios
5-year trend
EBITDA margin
28,3 %
This company
15,8 %
Market median
This company
Market median
79% above market
2023
2026
Equity ratio
51,8 %
This company
38,2 %
Market median
This company
Market median
36% above market
2023
2026
Return on equity
69,3 %
This company
18,4 %
Market median
This company
Market median
277% above market
2023
2026
Net profit margin
20,5 %
This company
8,1 %
Market median
This company
Market median
153% above market
2023
2026
Asset turnover
1,75×
This company
1,12×
Market median
This company
Market median
56% above market
2023
2026
Debt / equity
0,93×
This company
0,62×
Market median
This company
Market median
50% above market
2023
2026
Annual reports & filings
Annual report 2026
Filed via Bolagsverket / SCB · Period 2025-02-01 – 2026-01-31
View
PDF
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-02-01 – 2025-01-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-02-01 – 2024-01-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2021-11-23 – 2023-01-31
View
PDF
More on Tomaderm AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
